Dr. Thomas Flaig named Chair of the Association of American Medical Colleges (AAMC) Biomedical Research Advancement, Training and Oversight Group Steering Committee
Congratulations to the Director of Criterium’s Academic Urology Research Investigators Consortium (AURIC), Thomas Flaig, M.D. of the University of Colorado Anschutz, for being named chair of the Association of American Medical Colleges (AAMC) Biomedical Research Advancement, Training and Oversight Group Steering Committee.
Exploring new treatment options for HER2-Altered non-small cell lung cancer (NSCLC)
Arthi Sridhar, M.D., from the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC) and UT Southwestern Medical Center, reviews treatment options for HER2-Altered non-small cell lung cancer (NSCLC).
Evaluating a promising new treatment for pancreatic cancer
Wells Messersmith, M.D., from UC Health and the Director of Criterium’s Academic GI Cancer Consortium (AGICC), discusses a promising new treatment for pancreatic cancer.
New research explores a valuable therapeutic approach for treating gliobastoma
Andrew J. Brenner, M.D., Ph.D., from the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC) and the University of Texas Health Science Center, co-authored a paper exploring a valuable therapeutic approach for treating glioblastoma, combining Protein Arginine Methyltransferase 5 (PRMT5) inhibition and Temozolomide (TMZ).
Reviewing the potential of intravesical therapy in muscle-invasive bladder cancer
Melissa Reimers, M.D., from the Academic Urology Research Investigators Consortium (AURIC) and Washington University, discusses the potential of intravesical therapy in muscle-invasive bladder cancer.
Personalized treatment planning to avoid chemotherapy and surgery
In a treatment plan designed by Sunnie Kim, M.D., of UCHealth Cancer Care and the Academic GI Cancer Consortium (AGICC), using immunotherapy drugs spared a patient from undergoing chemotherapy and surgery.
Helping young patients navigate cancer recovery
With comprehensive treatment plans, Bennett A Caughey, M.D., of Criterium’s Academic GI Cancer Consortium (AGICC) and the Mass General Brigham Cancer Institute, is helping young patients navigate cancer recovery.
